Header cover image

Chinese (SSE) Pharma Industry Analysis

UpdatedJan 31, 2023
DataAggregated Company Financials
Companies213
  • 7D-0.09%
  • 3M7.1%
  • 1Y0.6%
  • YTD5.6%

The Pharma industry has been flat over the last week, but Shandong Shanda Wit Science and Technology has lost 8.7%. In line with that, the industry has also been flat over the past 12 months. Earnings are forecast to grow by 24% annually.

Industry Valuation and Performance

Has the Chinese Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 31 Jan 2023CN„2.9tCN„771.3bCN„83.2b35.4x35x3.8x
Thu, 29 Dec 2022CN„2.7tCN„771.4bCN„82.1b33.7x32.5x3.5x
Sat, 26 Nov 2022CN„2.8tCN„767.8bCN„81.9b36.7x33.9x3.6x
Mon, 24 Oct 2022CN„2.6tCN„760.7bCN„82.9b33.8x31.9x3.5x
Wed, 21 Sep 2022CN„2.4tCN„759.6bCN„79.4b30.5x30.5x3.2x
Fri, 19 Aug 2022CN„2.6tCN„753.5bCN„81.0b31.2x32.4x3.5x
Sun, 17 Jul 2022CN„2.7tCN„744.9bCN„81.0b31x33.5x3.6x
Tue, 14 Jun 2022CN„2.6tCN„740.2bCN„82.0b31.3x32x3.5x
Thu, 12 May 2022CN„2.6tCN„740.3bCN„81.7b32.3x32x3.5x
Sat, 09 Apr 2022CN„2.8tCN„724.6bCN„76.0b34x36.4x3.8x
Mon, 07 Mar 2022CN„2.9tCN„726.3bCN„77.4b33.7x37.5x4x
Wed, 02 Feb 2022CN„2.7tCN„721.5bCN„73.6b32.1x37.2x3.8x
Fri, 31 Dec 2021CN„3.1tCN„718.2bCN„73.2b36.6x42.6x4.3x
Sun, 28 Nov 2021CN„3.0tCN„717.1bCN„73.0b31.8x41.3x4.2x
Tue, 26 Oct 2021CN„2.8tCN„704.5bCN„73.5b30.3x38.8x4x
Thu, 23 Sep 2021CN„2.8tCN„702.7bCN„71.2b32.6x39.9x4x
Sat, 21 Aug 2021CN„2.8tCN„702.6bCN„71.1b29.6x38.9x3.9x
Sat, 05 Jun 2021CN„3.2tCN„680.8bCN„69.7b34x46.6x4.8x
Tue, 09 Mar 2021CN„3.0tCN„646.4bCN„64.7b32.2x46.6x4.7x
Mon, 30 Nov 2020CN„2.9tCN„635.4bCN„47.7b35.2x59.7x4.5x
Thu, 03 Sep 2020CN„3.3tCN„626.5bCN„45.7b43.1x71.8x5.2x
Sun, 07 Jun 2020CN„2.5tCN„629.7bCN„43.4b39.2x58.1x4x
Sat, 29 Feb 2020CN„2.3tCN„644.0bCN„46.9b34.3x48.7x3.6x
Price to Earnings Ratio

49.5x


Total Market Cap: CN„2.3tTotal Earnings: CN„46.9bTotal Revenue: CN„644.0bTotal Market Cap vs Earnings and Revenue0%0%0%
Chinese Pharma Industry Price to Earnings3Y Average 45x202120222023
Current Industry PE
  • Investors are pessimistic on the Chinese Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 35.2x which is lower than its 3-year average PE of 45.2x.
  • The industry is trading close to its 3-year average PS ratio of 4.1x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 21% per year over the last three years.
  • Revenues for these companies have grown 6.2% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Chinese Healthcare industry?

CN Market0.71%
Healthcare-0.55%
Pharma-0.087%
Pharma-0.087%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
688506 Sichuan Biokin PharmaceuticalLtdCN„65.5023.9%
+CN„5.1b
n/aPS33x
600518 Kangmei PharmaceuticalCN„2.173.3%
+CN„970.5m
-32.0%PE3.7x
300723 ApicHope PharmaceuticalCN„41.918.3%
+CN„922.1m
50.8%PE42.3x
600216 Zhejiang MedicineCN„12.496.7%
+CN„747.5m
-17.6%PE15.4x
300026 Tianjin Chase Sun PharmaceuticalLtdCN„6.243.8%
+CN„691.0m
1.1%PE36x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

2821

CN„159.60

Asymchem Laboratories (Tianjin)

7D

-5.6%

1Y

-31.4%

600276

CN„42.21

Jiangsu Hengrui Medicine

7D

-3.1%

1Y

3.1%

661

CN„201.10

Changchun High-Tech Industries (Group)

7D

-3.6%

1Y

15.2%

688506

CN„65.50

Sichuan Biokin PharmaceuticalLtd

7D

23.9%

1Y

n/a

300723

CN„41.91

ApicHope Pharmaceutical

7D

8.3%

1Y

50.8%

300357

CN„56.50

Zhejiang Wolwo Bio-Pharmaceutical

7D

1.9%

1Y

22.7%

600196

CN„34.02

Shanghai Fosun Pharmaceutical (Group)

7D

-6.3%

1Y

-20.0%

300026

CN„6.24

Tianjin Chase Sun PharmaceuticalLtd

7D

3.8%

1Y

1.1%

603858

CN„19.18

Shandong Buchang Pharmaceuticals

7D

-9.7%

1Y

-3.2%

688356

CN„174.20

Jenkem Technology

7D

6.2%

1Y

-17.2%

600518

CN„2.17

Kangmei Pharmaceutical

7D

3.3%

1Y

-32.0%

600216

CN„12.49

Zhejiang Medicine

7D

6.7%

1Y

-17.6%

600079

CN„26.57

Humanwell Healthcare (Group)Ltd

7D

-3.2%

1Y

35.5%

300725

CN„83.51

PharmaBlock Sciences (Nanjing)

7D

-7.9%

1Y

-3.0%

2653

CN„24.19

Haisco Pharmaceutical Group

7D

1.9%

1Y

39.7%